Genetic Differences Behind Toddler Activity Also Linked to ADHD Risk, Study Finds

IMT News Desk
IMT News Desk
· 2 min read
Genetic differences driving toddler activity levels may also increase ADHD risk, helping explain early behavioural traits and future diagnosis.

Genetic variations that influence how active toddlers are may also be associated with a higher likelihood of attention deficit hyperactivity disorder (ADHD) later in life, according to a large international study. Researchers analysed data from nearly 80,000 infants from multiple British and European cohort studies. They found that about 10 per cent of the differences in toddlers’ activity levels could be explained by common genetic variants. Many of these genetic markers strongly overlapped with those already known to increase the chance of developing ADHD, a neurodevelopmental condition characterised by short attention spans and impulsive, restless behaviour.

“We did not know until now that the genetic basis of ADHD was shared with these early behavioural traits,” said first author Anja Hollowell of the Universities of Surrey and Birkbeck, UK, referring to the activity levels displayed in toddlers. She added, “Our findings show that very early activity levels are influenced by many of the same genetic markers that influence later ADHD. Earlier identification of ADHD would be very helpful for providing timely support to children and their families.”

The team identified genetic markers in the gene RHEBL1 that were associated with lower activity levels in toddlers and also appeared to increase the activity of the RHEBL1 gene in the brain’s cortex, a key region involved in cognition and behaviour. Lead author Angelica Ronald, Professor of Psychology and Genetics at the University of Surrey, said the period from 12 to 36 months is marked by rapid skill development and wide variation in how much young children move around, with activity levels shaping learning, exploration, motor skills and even the type of parenting they receive.

“For the first time, we have identified the genetic variation associated with these early behavioural traits in toddlers. Our work highlights the significance of ‘nature’ in a young child’s behaviour,” Ronald said. She noted that the study complements existing research on environmental influences in early childhood and advances understanding of how genetic and biological pathways contribute to individual differences in child development. The researchers say their findings open new avenues for exploring how early activity patterns are driven by biology and how they relate to brain development, learning and later mental health, including ADHD.

Read Next

India’s first focused health AI Conclave unites doctors and AI experts
Featured Article
July 10, 2026

India’s first focused health AI Conclave unites doctors and AI experts

• Global Healthcare Academy hosts HAI Conclave 2026, India’s first national platform dedicated to Healthcare and Artificial Intelligence • Landmark Bengaluru conference brings together healthcare leaders and AI experts to explore how Artificial Intelligence can make healthcare faster, safer and more accessible while keeping patients at the centre of every decision The inaugural edition of the HAI Conclave […]
Article by: IMT News Desk
Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026
News
July 10, 2026

Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026

Fischer Medical Ventures Limited (FMVL) has announced that its strategic partner, Nanyang Biologics, has achieved a major international milestone with its AI-powered molecular research platform, NYB.AI, being featured in the opening showcase at NVIDIA GTC Taiwan 2026, ahead of the keynote address by NVIDIA Founder and CEO Jensen Huang. The recognition places NYB.AI among a […]
Article by: IMT News Desk
Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs
News
July 10, 2026

Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs

Indian pharmaceutical companies are expected to report healthy revenue growth in the first quarter of FY27, but margins are likely to compress as sector profitability comes under pressure. In a recent preview note, Goldman Sachs said it anticipates around 185 basis points year-on-year margin decline for the sector in the June quarter, driven primarily by […]
Article by: IMT News Desk
Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue
News
July 10, 2026

Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue

Dr Reddy’s Laboratories has announced a delay in commercial supplies of its semaglutide product after certain batches were found to be out of specification due to an issue with the active pharmaceutical ingredient (API) used in the drug. The company said it has initiated an investigation into the root cause and is taking corrective measures […]
Article by: IMT News Desk